SELENOV
gene geneOn this page
Also known as SELV
Summary
SELENOV (selenoprotein V, HGNC:30399) is a protein-coding gene on chromosome 19q13.2, encoding Selenoprotein V (P59797). May be involved in a redox-related process.
This gene encodes a selenoprotein containing a selenocysteine (Sec) residue, which is encoded by the UGA codon that normally signals translation termination. The 3’ UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, the Sec insertion sequence (SECIS) element, which is necessary for the recognition of UGA as a Sec codon rather than as a stop signal. This protein is specifically expressed in the testis. It belongs to the SelWTH family, which possesses a thioredoxin-like fold and a conserved CxxU (C is cysteine, U is Sec) motif, suggesting a redox function for this gene. Alternatively spliced transcript variants have been found for this gene.
Source: NCBI Gene 348303 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 69 total
- MANE Select transcript:
NM_182704
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30399 |
| Approved symbol | SELENOV |
| Name | selenoprotein V |
| Location | 19q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SELV |
| Ensembl gene | ENSG00000186838 |
| Ensembl biotype | protein_coding |
| OMIM | 607919 |
| Entrez | 348303 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 1 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay
ENST00000335426, ENST00000597876, ENST00000600586
RefSeq mRNA: 2 — MANE Select: NM_182704
NM_001350809, NM_182704
CCDS: CCDS54266
Canonical transcript exons
ENST00000335426 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001339575 | 39518903 | 39518977 |
| ENSE00002052574 | 39518608 | 39518632 |
| ENSE00003502858 | 39519071 | 39519170 |
| ENSE00003668851 | 39518740 | 39518793 |
| ENSE00003978235 | 39520146 | 39520675 |
| ENSE00003978236 | 39515139 | 39516021 |
Expression profiles
Bgee: expression breadth broad, 60 present calls, max score 79.25.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1483 / max 18.9456, expressed in 92 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 175789 | 0.1215 | 82 |
| 175788 | 0.0268 | 3 |
Top tissues by expression
100 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 79.25 | gold quality |
| right testis | UBERON:0004534 | 78.14 | gold quality |
| testis | UBERON:0000473 | 78.13 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 72.99 | gold quality |
| thyroid gland | UBERON:0002046 | 72.96 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 72.66 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 70.83 | gold quality |
| mucosa of stomach | UBERON:0001199 | 50.67 | gold quality |
| temporal lobe | UBERON:0001871 | 49.44 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 49.42 | gold quality |
| amygdala | UBERON:0001876 | 49.34 | gold quality |
| nucleus accumbens | UBERON:0001882 | 47.95 | gold quality |
| calcaneal tendon | UBERON:0003701 | 47.59 | silver quality |
| hypothalamus | UBERON:0001898 | 47.29 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 46.73 | gold quality |
| Ammon’s horn | UBERON:0001954 | 46.32 | gold quality |
| putamen | UBERON:0001874 | 46.04 | gold quality |
| left ovary | UBERON:0002119 | 45.80 | gold quality |
| colonic epithelium | UBERON:0000397 | 45.57 | gold quality |
| cerebral cortex | UBERON:0000956 | 45.37 | gold quality |
| prefrontal cortex | UBERON:0000451 | 45.21 | gold quality |
| frontal cortex | UBERON:0001870 | 45.01 | gold quality |
| ovary | UBERON:0000992 | 44.88 | gold quality |
| pituitary gland | UBERON:0000007 | 44.17 | gold quality |
| right frontal lobe | UBERON:0002810 | 44.05 | gold quality |
| brain | UBERON:0000955 | 43.97 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 43.84 | gold quality |
| right ovary | UBERON:0002118 | 43.26 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 42.94 | gold quality |
| primary visual cortex | UBERON:0002436 | 42.92 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.12 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
16 targeting SELENOV, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-6887-3P | 99.66 | 67.83 | 1778 |
| HSA-MIR-6837-5P | 99.25 | 65.47 | 1632 |
| HSA-MIR-4685-5P | 99.25 | 65.99 | 1563 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
| HSA-MIR-4426 | 99.17 | 66.74 | 1949 |
| HSA-MIR-4662B | 98.33 | 66.37 | 1163 |
| HSA-MIR-4647 | 98.30 | 66.41 | 1139 |
| HSA-MIR-3652 | 97.71 | 65.43 | 1890 |
| HSA-MIR-192-3P | 97.52 | 67.66 | 1001 |
| HSA-MIR-4430 | 97.47 | 65.61 | 1813 |
| HSA-MIR-600 | 97.07 | 66.73 | 1259 |
| HSA-MIR-7161-3P | 96.79 | 68.79 | 798 |
| HSA-MIR-617 | 96.79 | 65.96 | 738 |
| HSA-MIR-4522 | 95.76 | 66.23 | 742 |
| HSA-MIR-492 | 94.02 | 64.46 | 413 |
Literature-anchored findings (GeneRIF, showing 1)
- The SS concentrations that lead to a decrease in the viability of human prostate adenocarcinoma cells (line Du-145) have been selected, and the effect of sodium selenite on the expression of mRNA of the SELV, SELW, and TGR selenocysteine proteins in these cells has been analyzed. (PMID:29989584)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Selenov | ENSMUSG00000046750 |
| rattus_norvegicus | Selenov | ENSRNOG00000051208 |
Paralogs (2): MIEN1 (ENSG00000141741), SELENOW (ENSG00000178980)
Protein
Protein identifiers
Selenoprotein V — P59797 (reviewed: P59797)
All UniProt accessions (2): M0QZN9, P59797
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in a redox-related process.
Tissue specificity. Testis specific.
Post-translational modifications. Truncated SELENOV proteins produced by failed UGA/Sec decoding are ubiquitinated by the CRL2(APPBP2) complex, which recognizes the glycine (Gly) at the C-terminus of truncated SELENOV proteins.
Similarity. Belongs to the SelWTH family.
RefSeq proteins (2): NP_001337738, NP_874363* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR011893 | Selenoprotein_Rdx-typ | Family |
| IPR036249 | Thioredoxin-like_sf | Homologous_superfamily |
| IPR051441 | SelW_related | Family |
Pfam: PF10262
UniProt features (7 total): region of interest 2, chain 1, compositionally biased region 1, non-standard amino acid 1, cross-link 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
No AlphaFold model available for P59797 — AlphaFold DB does not currently provide models for proteins above ~3000 aa.
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 270–273
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 37 (showing top):
CAGGTCC_MIR492, KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION, MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED, MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3, MIKKELSEN_MEF_HCP_WITH_H3K27ME3, ZNF282_TARGET_GENES, ZNF664_TARGET_GENES, MIR4426, MIR7161_3P, MIR4647_MIR4662B, GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP, GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN, WP_SELENIUM_MICRONUTRIENT_NETWORK, DESCARTES_MAIN_FETAL_METANEPHRIC_CELLS, DESCARTES_FETAL_PANCREAS_DUCTAL_CELLS
GO Biological Process (1): response to selenium ion (GO:0010269)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): cytosol (GO:0005829)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| response to chemical | 1 |
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
362 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SELENOV | SELENOT | P62341 | 873 |
| SELENOV | SELENOK | Q9Y6D0 | 854 |
| SELENOV | SELENOH | Q8IZQ5 | 852 |
| SELENOV | SELENOO | Q9BVL4 | 831 |
| SELENOV | SELENOS | Q9BQE4 | 804 |
| SELENOV | SELENOF | O60613 | 799 |
| SELENOV | SELENOI | Q9C0D9 | 796 |
| SELENOV | SEPHS2 | Q99611 | 789 |
| SELENOV | SELENON | Q9NZV5 | 776 |
| SELENOV | SELENOM | Q8WWX9 | 775 |
| SELENOV | SECISBP2 | Q96T21 | 762 |
| SELENOV | MSRB1 | Q9NZV6 | 738 |
| SELENOV | TXNRD3 | Q86VQ6 | 730 |
| SELENOV | SELENOP | P49908 | 669 |
| SELENOV | TXNRD1 | Q16881 | 624 |
IntAct
34 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SELENOV | ZMYND19 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZMYND19 | SELENOV | psi-mi:“MI:0915”(physical association) | 0.720 |
| SELENOV | PRR20C | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLGA2 | SELENOV | psi-mi:“MI:0915”(physical association) | 0.560 |
| SELENOV | ZMIZ2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SELENOV | APPBP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRR20C | SELENOV | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZMIZ2 | SELENOV | psi-mi:“MI:0915”(physical association) | 0.560 |
| APPBP2 | SELENOV | psi-mi:“MI:0915”(physical association) | 0.560 |
| SELENOV | GOLGA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSF2BP | SELENOV | psi-mi:“MI:0915”(physical association) | 0.560 |
| SELENOV | EFHC1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SELENOV | PIN1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SELENOV | NTAQ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SELENOV | QRICH1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZMYND19 | SELENOV | psi-mi:“MI:0915”(physical association) | 0.000 |
| HSF2BP | SELENOV | psi-mi:“MI:0915”(physical association) | 0.000 |
| EFHC1 | SELENOV | psi-mi:“MI:0915”(physical association) | 0.000 |
| PIN1 | SELENOV | psi-mi:“MI:0915”(physical association) | 0.000 |
| NTAQ1 | SELENOV | psi-mi:“MI:0915”(physical association) | 0.000 |
| QRICH1 | SELENOV | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (14): SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), QRICH1 (Two-hybrid), SELV (Two-hybrid), SELV (Two-hybrid), SELV (Affinity Capture-Western)
ESM2 similar proteins: A0A0J9YWL9, A0A0J9YY54, A0A0U1RQI7, A0A494C071, A6NNC1, A6QL64, B3KS81, D3YZV8, E2RYF7, E9Q6E9, F1LWT0, F8W0I5, O60732, P0C8Z4, P0DKJ7, P0DKJ8, P0DKL2, P0DPF3, P18751, P20930, P43537, P53353, P59797, P62521, Q01456, Q08AG5, Q12816, Q3BBV2, Q5H9R4, Q5HY64, Q5JPF3, Q6P902, Q6ZQX7, Q86T75, Q86VE3, Q86VQ3, Q8BGJ3, Q8N307, Q8N7U7, Q8N7X1
Diamond homologs: D0EYG3, O19097, P59797, P63300, P63301, P63302, P63303, Q148C8, Q568W0, Q5NVB2, Q95KL4, Q9BRT3, Q9CQ86, Q9STZ2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
69 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 62 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
827 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:39516019:CTGG:C | donor_loss | 1.0000 |
| 19:39516020:TGGTG:T | donor_loss | 1.0000 |
| 19:39516021:GGTG:G | donor_loss | 1.0000 |
| 19:39516022:G:C | donor_loss | 1.0000 |
| 19:39516022:G:GG | donor_gain | 1.0000 |
| 19:39518738:A:AG | acceptor_gain | 1.0000 |
| 19:39518739:G:GG | acceptor_gain | 1.0000 |
| 19:39519062:T:TA | acceptor_gain | 1.0000 |
| 19:39516023:T:A | donor_loss | 0.9900 |
| 19:39518579:A:AG | acceptor_gain | 0.9900 |
| 19:39518580:A:G | acceptor_gain | 0.9900 |
| 19:39518592:T:A | acceptor_gain | 0.9900 |
| 19:39518598:T:TA | acceptor_gain | 0.9900 |
| 19:39518606:A:AG | acceptor_gain | 0.9900 |
| 19:39518607:G:GG | acceptor_gain | 0.9900 |
| 19:39518607:GT:G | acceptor_gain | 0.9900 |
| 19:39518739:GT:G | acceptor_gain | 0.9900 |
| 19:39518739:GTA:G | acceptor_gain | 0.9900 |
| 19:39518739:GTAC:G | acceptor_gain | 0.9900 |
| 19:39518794:G:GG | donor_gain | 0.9900 |
| 19:39518988:G:GG | donor_gain | 0.9900 |
| 19:39519006:G:T | donor_gain | 0.9900 |
| 19:39519064:T:TA | acceptor_gain | 0.9900 |
| 19:39519069:AGAG:A | acceptor_gain | 0.9900 |
| 19:39519069:AGAGG:A | acceptor_gain | 0.9900 |
| 19:39519070:GAGG:G | acceptor_gain | 0.9900 |
| 19:39519070:GAGGG:G | acceptor_gain | 0.9900 |
| 19:39516017:TACTG:T | donor_gain | 0.9800 |
| 19:39516020:TG:T | donor_gain | 0.9800 |
| 19:39516021:GG:G | donor_gain | 0.9800 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000046545 (19:39519590 C>T), RS1000967317 (19:39516575 T>C), RS1000997495 (19:39515627 C>G,T), RS1001375560 (19:39520531 A>G), RS1001445444 (19:39515110 TCG>T), RS1001560716 (19:39518036 G>A), RS1001851542 (19:39513506 C>A), RS1002536506 (19:39513689 C>T), RS1002854153 (19:39516059 A>T), RS1002971551 (19:39518954 G>A,C), RS1003917037 (19:39518922 A>C), RS1004089935 (19:39513431 T>C), RS1004351057 (19:39518585 C>G,T), RS1005614396 (19:39520206 G>A), RS1005816991 (19:39514393 G>A,C)
Disease associations
OMIM: gene MIM:607919 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.